Atezolizumab (Tecentriq (R)): Activity, indication and modality of use in advanced or metastatic urinary bladder carcinoma

Bernard-Tessier, A; Bonnet, C; Lavaud, P; Gizzi, M; Loriot, Y; Massard, C

Massard, C (reprint author), Gustave Roussy Canc Campus, Drug Dev Dept, 114 Rue Edouard Vaillant, F-94805 Villejuif, France.; Massard, C (reprint author), Dept Med Oncol, 114 Rue Edouard Vaillant, F-94805 Villejuif, France.

BULLETIN DU CANCER, 2018; 105 (2): 140

Abstract

Treatments for patients with metastatic or advanced urothelial carcinomas on progression after first line chemotherapy or unfit for cisplatin are curr......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索